Spots Global Cancer Trial Database for leuprolide mesylate
Every month we try and update this database with for leuprolide mesylate cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Safety, Efficacy, and Pharmacokinetic Behavior of Leuprolide Mesylate in Subjects With Advanced Prostate Carcinoma | NCT02234115 | Prostatic Neopl... | Leuprolide Mesy... | 18 Years - | Foresee Pharmaceuticals Co., Ltd. | |
Safety, Efficacy, and Pharmacokinetic Behavior of Leuprolide Mesylate (LMIS 25 mg) in Subjects With Prostate Cancer | NCT03261999 | Prostatic Neopl... | Leuprolide Mesy... | 18 Years - | Foresee Pharmaceuticals Co., Ltd. |